| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2db1eb4f46cbdcc40a8795011a1fe210 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2001-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97be96017ab5c7d5c861dc6f907aab20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49f2d295d92b87b25557b08dee6781df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f93ca64fb9b13d35daed06ee10617e37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9d3e62b0105cc087e637abd0026b1b9 |
| publicationDate |
2003-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1305035-A1 |
| titleOfInvention |
Naadp analogues for modulating t-cell activity |
| abstract |
A method for modulating T cell activity by modulating the intracellular concentration and/or activity of NAADP+, compounds capable of modulating the effect of NAADP+ on T cell Ca2+ levels, and methods for identifying the same, are described. |
| priorityDate |
2000-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |